-
Mar 7, 2021
-
Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for cancer, has been awarded £350K (approximately US$475K) in the form of a Smart Grant from Innovate UK, to accelerate their cancer immunotherapy programme targeting the innate immune checkpoint, GPR65.
Mar 7, 2021
-
Cytel has launched East Bayes®, an enhanced web-based extension of the East® platform that enables adoption of the most computationally intensive Bayesian clinical trial designs – without the need for powerful on-site computers.
Mar 7, 2021
-
Feb 11, 2021
-
SPT Labtech has announced the acquisition of BioMicroLab – a deal that strategically expands SPT Labtech’s offering in sample management for life sciences.
Feb 15, 2021
-
AnteoTech’s long-term customer Ellume has secured a $231.8 million agreement with the U.S. Government to support accelerated manufacture of its rapid COVID-19 Home Test.
Feb 15, 2021
-
Dear Madam, dear Sir,
We are pleased to send you the Press Release related to the CE Mark certification of our Microsemi CRP New Generation.
You can also find product information on our website:
https://www.horiba.com/en_en/medical/products/detail/action/show/Product/3302/
and our teasing video on our social media:
https://www.linkedin.com/feed/update/urn:li:activity:6767482155384754177
https://www.youtube.com/watch?v=lN9ru0Nq_wM
https://www.facebook.com/horibamedical/videos/752041212412467
https://twitter.com/horibamedical/status/1361716442668953600
We remain at your disposal for any questions you may have.
Very best regards,
Feb 16, 2021
-
Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrates their 5th anniversary with the unveiling of a new and expanded, next-generation robotic platform, Ulysses, which plays a central catalytic role in drug discovery.
Feb 15, 2021
-
Thermo Fisher Scientific today announced the launch of its flexible, online 2D-liquid chromatography (LC) systems.
Feb 16, 2021
-
Medical technology specialist Gerresheimer has developed the test cartridge and reagent block for a fully automatic blood analyzer which can be used to identify a number of biomarkers for various diseases right at the point of care. On behalf of customer CAMPTON Diagnostics, the design of the unit test cartridge and reagent block was optimized for series production through injection molding and the easiest possible handling.
Feb 16, 2021
-
Feb 17, 2021
-
The UK Healthcare Pavilion has launched a new virtual platform to bring together life sciences companies, hospitals, clinics, and key organisations — helping global customers discover, connect and innovate.
Feb 22, 2021
-
Feb 23, 2021
-
Feb 23, 2021
-
Feb 24, 2021
-
Atik Cameras, a specialist designer and manufacturer of advanced scientific imaging solutions, has further expanded its collaboration with leading global Original Equipment Manufacturers (OEMs) of real time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply high-performing cameras for reliable COVID-19 testing.
Feb 24, 2021
-
Quinten, a pioneer in AI-powered decision support solutions, has launched Quinten Health — a global and integrated analytical services and tools development offer.
Feb 28, 2021
-
Immudex ApS, the sole proprietor of DNA barcoded MHC multimer technology, has announced the launch of dCODE Dextramer® (RiO) — a new reagent compatible with BD Rhapsody™ Single Cell Analysis system for multiplexing, allowing the identification of many different T-cell specificities in the same sample. Creating personalized dCODE Dextramer® libraries, is possible to profile T cells and get a new understanding of T-cell immunity.
Jan 31, 2021
-
VERICHEM LABORATORIES has announced that it has expanded the available test reporting options that it offers with its Calibration Verification Data Reduction Program.
Jan 31, 2021
-
Albumedix Ltd., the world leader in recombinant human albumin, has entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
Feb 1, 2021